Alternative Transition Trajectories for Complementary Asset Markets in China's Pharmaceutical Industry

Steven White and Xielin Liu
Additional contact information
Steven White: Research Institute for Economics & Business Administration (RIEB), Kobe University, Japan

No 83, Discussion Paper Series from Research Institute for Economics & Business Administration, Kobe University

Abstract: As the State relinquishes its role as coordinator of interorganizational asset transfers, how do interdendent suppliers and users of complementary assets find each other and manage transactions for these assets? This study compares the emerging market structure of two different types of complementary assets in the pharmaceutical industry - new product technology (R&D) and sales and distribution (Wholesaling).

Keywords: Pharmaceutical industry; Financial market (search for similar items in EconPapers)
JEL-codes: D23 L65 (search for similar items in EconPapers)
Pages: 29 pages
Date: 1997-09
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:kob:dpaper:83

Access Statistics for this paper

More papers in Discussion Paper Series from Research Institute for Economics & Business Administration, Kobe University 2-1 Rokkodai, Nada, Kobe 657-8501 JAPAN. Contact information at EDIRC.
Bibliographic data for series maintained by Office of Promoting Research Collaboration, Research Institute for Economics & Business Administration, Kobe University ().